Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > Biophan Expands Biotechnology IP Portfolio to 114 Patents

March 29th, 2005

Biophan Expands Biotechnology IP Portfolio to 114 Patents

Abstract:
Biophan Technologies, Inc., a developer of next-generation biomedical technology, has announced continued growth of its intellectual property portfolio, reaching a total of 114 issued or filed patents in a range of cutting-edge biomedical fields. The newly-issued patents and recent patent applications claim important additional intellectual property coverage for the Company as it continues its development of advanced solutions for Magnetic Resonance Imaging (MRI) safety and image compatibility for surgical instruments and implanted devices, and other markets.

Source:
businesswire

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

Researchers uncover strong light-matter interactions in quantum spin liquids: Groundbreaking experiment supported by Rice researcher reveals new insights into a mysterious phase of quantum matter December 13th, 2024

FSU researchers develop new methods to generate and improve magnetism of 2D materials December 13th, 2024

Innovative biomimetic superhydrophobic coating combines repair and buffering properties for superior anti-erosion December 13th, 2024

Groundbreaking research unveils unified theory for optical singularities in photonic microstructures December 13th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project